Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Lysosomal Storage Diseases Therapeutics market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Lysosomal Storage Diseases Therapeuticsmarket, defines the market attractiveness level of Lysosomal Storage Diseases Therapeutics market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Lysosomal Storage Diseases Therapeutics industry, describes the types of Lysosomal Storage Diseases Therapeutics market, the applications of major players and the market size, and deeply analyzes the current situation of the global Lysosomal Storage Diseases Therapeutics market and the development prospects and opportunities of Lysosomal Storage Diseases Therapeutics industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Lysosomal Storage Diseases Therapeutics market in Chapter 13.
By Player:
Sanofi
Shire
Pfizer
Amicus Therapeutics
BioMarin Pharmaceutical
Actelion Ltd
Raptor Pharmaceutical
Protalix Biotherapeutics
By Type:
Enzyme Replacement Therapy
Stem Cell Therapy
Substrate Reduction Therapy
Other
By End-User:
Hospitals
Clinics
Other
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Lysosomal Storage Diseases Therapeutics Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Lysosomal Storage Diseases Therapeutics Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Lysosomal Storage Diseases Therapeutics Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Lysosomal Storage Diseases Therapeutics Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Lysosomal Storage Diseases Therapeutics Market Analysis and Outlook to 2022
-
7.1 Global Lysosomal Storage Diseases Therapeutics Consumption (2017-2022)
-
7.2 United States Lysosomal Storage Diseases Therapeutics Consumption (2017-2022)
-
7.3 Europe Lysosomal Storage Diseases Therapeutics Consumption (2017-2022)
-
7.4 China Lysosomal Storage Diseases Therapeutics Consumption (2017-2022)
-
7.5 Japan Lysosomal Storage Diseases Therapeutics Consumption (2017-2022)
-
7.6 India Lysosomal Storage Diseases Therapeutics Consumption (2017-2022)
-
7.7 South Korea Lysosomal Storage Diseases Therapeutics Consumption (2017-2022)
8 Region and Country-wise Lysosomal Storage Diseases Therapeutics Market Analysis and Outlook to 2028
-
8.1 Global Lysosomal Storage Diseases Therapeutics Consumption Forecast (2022-2028)
-
8.2 United States Lysosomal Storage Diseases Therapeutics Consumption Forecast (2022-2028)
-
8.3 Europe Lysosomal Storage Diseases Therapeutics Consumption Forecast (2022-2028)
-
8.4 China Lysosomal Storage Diseases Therapeutics Consumption Forecast (2022-2028)
-
8.5 Japan Lysosomal Storage Diseases Therapeutics Consumption Forecast (2022-2028)
-
8.6 India Lysosomal Storage Diseases Therapeutics Consumption Forecast (2022-2028)
-
8.7 South Korea Lysosomal Storage Diseases Therapeutics Consumption Forecast (2022-2028)
9 Global Lysosomal Storage Diseases Therapeutics Market Outlook by Types and Applications to 2022
-
9.1 Global Lysosomal Storage Diseases Therapeutics Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Enzyme Replacement Therapy Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Stem Cell Therapy Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Substrate Reduction Therapy Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Other Consumption and Growth Rate (2017-2022)
-
9.2 Global Lysosomal Storage Diseases Therapeutics Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Clinics Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Other Consumption and Growth Rate (2017-2022)
10 Global Lysosomal Storage Diseases Therapeutics Market Outlook by Types and Applications to 2028
-
10.1 Global Lysosomal Storage Diseases Therapeutics Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Enzyme Replacement Therapy Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Stem Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Substrate Reduction Therapy Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Other Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Lysosomal Storage Diseases Therapeutics Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Clinics Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Other Consumption Forecast and Growth Rate (2022-2028)
11 Global Lysosomal Storage Diseases Therapeutics Import and Export Analysis (Top 5 Countries)
-
11.1 Global Lysosomal Storage Diseases Therapeutics Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Lysosomal Storage Diseases Therapeutics Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Lysosomal Storage Diseases Therapeutics Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Lysosomal Storage Diseases Therapeutics Market Competitive Analysis
-
14.1 Sanofi
-
14.1.1 Sanofi Company Details
-
14.1.2 Sanofi Lysosomal Storage Diseases Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Sanofi Lysosomal Storage Diseases Therapeutics Product and Service
-
14.2 Shire
-
14.2.1 Shire Company Details
-
14.2.2 Shire Lysosomal Storage Diseases Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Shire Lysosomal Storage Diseases Therapeutics Product and Service
-
14.3 Pfizer
-
14.3.1 Pfizer Company Details
-
14.3.2 Pfizer Lysosomal Storage Diseases Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Pfizer Lysosomal Storage Diseases Therapeutics Product and Service
-
14.4 Amicus Therapeutics
-
14.4.1 Amicus Therapeutics Company Details
-
14.4.2 Amicus Therapeutics Lysosomal Storage Diseases Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Amicus Therapeutics Lysosomal Storage Diseases Therapeutics Product and Service
-
14.5 BioMarin Pharmaceutical
-
14.5.1 BioMarin Pharmaceutical Company Details
-
14.5.2 BioMarin Pharmaceutical Lysosomal Storage Diseases Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 BioMarin Pharmaceutical Lysosomal Storage Diseases Therapeutics Product and Service
-
14.6 Actelion Ltd
-
14.6.1 Actelion Ltd Company Details
-
14.6.2 Actelion Ltd Lysosomal Storage Diseases Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Actelion Ltd Lysosomal Storage Diseases Therapeutics Product and Service
-
14.7 Raptor Pharmaceutical
-
14.7.1 Raptor Pharmaceutical Company Details
-
14.7.2 Raptor Pharmaceutical Lysosomal Storage Diseases Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Raptor Pharmaceutical Lysosomal Storage Diseases Therapeutics Product and Service
-
14.8 Protalix Biotherapeutics
-
14.8.1 Protalix Biotherapeutics Company Details
-
14.8.2 Protalix Biotherapeutics Lysosomal Storage Diseases Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Protalix Biotherapeutics Lysosomal Storage Diseases Therapeutics Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Lysosomal Storage Diseases Therapeutics
-
Figure Lysosomal Storage Diseases Therapeutics Picture
-
Table Global Lysosomal Storage Diseases Therapeutics Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Lysosomal Storage Diseases Therapeutics Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Lysosomal Storage Diseases Therapeutics Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Lysosomal Storage Diseases Therapeutics Consumption by Country (2017-2022)
-
Figure United States Lysosomal Storage Diseases Therapeutics Consumption and Growth Rate (2017-2022)
-
Table Europe Lysosomal Storage Diseases Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure China Lysosomal Storage Diseases Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Japan Lysosomal Storage Diseases Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure India Lysosomal Storage Diseases Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure South Korea Lysosomal Storage Diseases Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Global Lysosomal Storage Diseases Therapeutics Consumption Forecast by Country (2022-2028)
-
Figure United States Lysosomal Storage Diseases Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Lysosomal Storage Diseases Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Lysosomal Storage Diseases Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Lysosomal Storage Diseases Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Lysosomal Storage Diseases Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Lysosomal Storage Diseases Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Enzyme Replacement Therapy Consumption and Growth Rate (2017-2022)
-
Figure Global Stem Cell Therapy Consumption and Growth Rate (2017-2022)
-
Figure Global Substrate Reduction Therapy Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global Hospitals Consumption and Growth Rate (2017-2022)
-
Figure Global Clinics Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global Enzyme Replacement Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Stem Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Substrate Reduction Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clinics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Lysosomal Storage Diseases Therapeutics Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Lysosomal Storage Diseases Therapeutics Export by Region (Top 5 Countries) (2017-2028)
-
Table Sanofi (Foundation Year, Company Profile and etc.)
-
Table Sanofi Lysosomal Storage Diseases Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi Lysosomal Storage Diseases Therapeutics Product and Service
-
Table Shire (Foundation Year, Company Profile and etc.)
-
Table Shire Lysosomal Storage Diseases Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Shire Lysosomal Storage Diseases Therapeutics Product and Service
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Lysosomal Storage Diseases Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Lysosomal Storage Diseases Therapeutics Product and Service
-
Table Amicus Therapeutics (Foundation Year, Company Profile and etc.)
-
Table Amicus Therapeutics Lysosomal Storage Diseases Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Amicus Therapeutics Lysosomal Storage Diseases Therapeutics Product and Service
-
Table BioMarin Pharmaceutical (Foundation Year, Company Profile and etc.)
-
Table BioMarin Pharmaceutical Lysosomal Storage Diseases Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table BioMarin Pharmaceutical Lysosomal Storage Diseases Therapeutics Product and Service
-
Table Actelion Ltd (Foundation Year, Company Profile and etc.)
-
Table Actelion Ltd Lysosomal Storage Diseases Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Actelion Ltd Lysosomal Storage Diseases Therapeutics Product and Service
-
Table Raptor Pharmaceutical (Foundation Year, Company Profile and etc.)
-
Table Raptor Pharmaceutical Lysosomal Storage Diseases Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Raptor Pharmaceutical Lysosomal Storage Diseases Therapeutics Product and Service
-
Table Protalix Biotherapeutics (Foundation Year, Company Profile and etc.)
-
Table Protalix Biotherapeutics Lysosomal Storage Diseases Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Protalix Biotherapeutics Lysosomal Storage Diseases Therapeutics Product and Service
-
